Your browser doesn't support javascript.
loading
Codon arrangement modulates MHC-I peptides presentation: implications for a SARS-CoV-2 peptide-based vaccine
Tariq Daouda; Maude Dumont-Lagacé; Albert Feghaly; Alexandra-Chloe Villani.
Affiliation
  • Tariq Daouda; Broad Institute of MIT and Harvard; Center for Cancer Research, Massachusetts General Hospital; Department of Medicine, Harvard Medical School; Center for Immu
  • Maude Dumont-Lagacé; Institute for Research in Immunology and Cancer; Université de Montréal
  • Albert Feghaly; Institute for Research in Immunology and Cancer; Université de Montréal
  • Alexandra-Chloe Villani; Broad Institute of MIT and Harvard; Center for Cancer Research, Massachusetts General Hospital; Department of Medicine, Harvard Medical School; Center for Immu
Preprint in English | bioRxiv | ID: ppbiorxiv-429819
ABSTRACT
Among various vaccination strategies, peptide-based vaccines appear as excellent candidates because they are cheap to produce, are highly stable and harbor low toxicity. However, predicting which MHC-I Associated Peptide (MAP) will ultimately reach cell surface remains challenging, due to high false discovery rates. Previously, we demonstrated that synonymous codon arrangement (usage and placement) is predictive of, and modulates MAP presentation. Here, we apply CAMAP (Codon Arrangement MAP Predictor), the artificial neural network we used to unveil the role of codon arrangement in MAP presentation, to predict SARS-CoV MAPs. We report that experimentally identified SARS-CoV-1 and SARS-CoV-2 MAPs are associated with significantly higher CAMAP scores. Based on CAMAP scores and binding affinity, we identified 48 non-overlapping MAP candidates for a peptide-based vaccine, ensuring coverage for a high proportion of HLA haplotypes in the US population (>78%) and SARS-CoV-2 strains (detected in >98% of SARS-CoV-2 strains present in the GISAID database). Finally, we built an interactive web portal (https//www.epitopes.world) where researchers can freely explore CAMAP predictions for SARS-CoV-1/2 viruses. Collectively, we present an analysis framework that can be generalizable to empower the rapid identification of virus-specific MAPs, including in the context of an emergent virus, to help accelerate target identification for peptide-based vaccine designs that could be critical in safely attaining group immunity in the context of a global pandemic.
License
cc_by_nd
Full text: Available Collection: Preprints Database: bioRxiv Type of study: Prognostic study Language: English Year: 2021 Document type: Preprint
Full text: Available Collection: Preprints Database: bioRxiv Type of study: Prognostic study Language: English Year: 2021 Document type: Preprint
...